RxDoctor Payments Data

Daniel Kuritzkes, MD

Internal Medicine · Boston, MANPI 1114917416

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $347,836 of the $443,350 with a category attached, or 78.5%. 12 manufacturers reported payments, led by Viiv Healthcare Company at 38.4% of the total. Reporting peaked in 2024 at $80,730 and has fallen 59.8% since, to $32,420 in 2025. Among internal medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$443,350in general payments, 2019–2025

Across 341 payments — averaging $1300.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$170K
  • Merck$111K
  • GSK$59K
  • Gilead$52K
  • Shionogi Inc$21K
  • AbbVie$12K
  • plus $19K from 6 others
$1,639,698in research payments, 2019–2025

Across 16 payments — averaging $102,481 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$811K
  • Novartis$605K
  • Viiv Healthcare Company$173K
  • Merck$50K

What the payments were for

  • Royalty or licence$4180%
  • Consulting fees$347,83678%
  • Speaking & faculty fees$5,1001%
  • Grants$4640%
  • Travel & lodging$82,29819%
  • Food & beverage$7,2242%
  • Education$110%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$443,350 in reported general payments places this provider in the 95th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$11,349
Medicare patients
46
Services billed
103

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →